Extracellular Matrix and Growth Factors During Heart Growth
暂无分享,去创建一个
[1] A. Chobanian,et al. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. , 1994, Circulation research.
[2] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[3] P. Jones,et al. Regulation of Tenascin-C, a Vascular Smooth Muscle Cell Survival Factor that Interacts with the αvβ3 Integrin to Promote Epidermal Growth Factor Receptor Phosphorylation and Growth , 1997, The Journal of cell biology.
[4] Robert,et al. Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[5] K. Weber,et al. Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.
[6] E Ruoslahti,et al. Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts. , 1998, The Journal of clinical investigation.
[7] A. Chobanian,et al. Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase. , 1995, The Journal of clinical investigation.
[8] A. Tedgui,et al. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta. Evidence for a pressure-induced tissue renin-angiotensin system. , 1996, Circulation research.
[9] E. Schiffrin,et al. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR. , 1997, Journal of cardiovascular pharmacology.
[10] J. Schaper,et al. The extracellular matrix in human myocardium: Part I: Collagens I, III, IV, and VI. , 1991, Cardioscience.
[11] B. Doble,et al. Regulation of Basic Fibroblast Growth Factor (BFGF) and FGF Receptors in the Heart a , 1995, Annals of the New York Academy of Sciences.
[12] E Ruoslahti,et al. A 60-kD protein mediates the binding of transforming growth factor-beta to cell surface and extracellular matrix proteoglycans , 1993, The Journal of cell biology.
[13] V. Koteliansky,et al. Laminin variants and integrin laminin receptors in developing and adult human smooth muscle. , 1993, Developmental biology.
[14] K. Baker,et al. Evidence for a role of an intracardiac renin-angiotensin system in normal and failing hearts. , 1993, Trends in cardiovascular medicine.
[15] P. Sil,et al. Angiotensin II and myocyte growth: role of fibroblasts. , 1997, Hypertension.
[16] L. d’Uscio,et al. Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-recep , 1997 .
[17] P. R. Myers,et al. Oxide Vascular Endothelial Cell Regulation of Extracellular Matrix Collagen : Role of Nitric , 1998 .
[18] T. Hardingham,et al. Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] G. Booz,et al. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. , 1992, Annual review of physiology.
[20] J. Thyberg,et al. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells , 1988, The Journal of cell biology.
[21] D. Mann,et al. Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. , 1998, Circulation.
[22] H. Hämmerle,et al. Orientation response of arterial smooth muscle cells to mechanical stimulation. , 1986, European journal of cell biology.
[23] H. Kim,et al. Expression of extracellular matrix components fibronectin and laminin in the human fetal heart. , 1999, Cell structure and function.
[24] B. Swynghedauw,et al. Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.
[25] T. Matsuda,et al. Mechanical Stress-Induced Orientation and Ultrastructural Change of Smooth Muscle Cells Cultured in Three-Dimensional Collagen Lattices , 1994, Cell transplantation.
[26] L. Silengo,et al. Muscle β1D Integrin Reinforces the Cytoskeleton–Matrix Link: Modulation of Integrin Adhesive Function by Alternative Splicing , 1997, The Journal of cell biology.
[27] P. Oliviéro,et al. Differential splicing of fibronectin pre-messenger ribonucleic acid during cardiac ontogeny and development of hypertrophy in the rat. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[28] J. Thiery,et al. Fibronectin and integrins in development. , 1993, Seminars in cancer biology.
[29] George Cooper,et al. Association of Tyrosine-phosphorylated c-Src with the Cytoskeleton of Hypertrophying Myocardium* , 1997, The Journal of Biological Chemistry.
[30] R. Fandrich,et al. Basic fibroblast growth factor in atria and ventricles of the vertebrate heart , 1989, The Journal of cell biology.
[31] G. Rosen,et al. Expanding roles for alpha 4 integrin and its ligands in development. , 1994, Cell adhesion and communication.
[32] A. Chobanian,et al. Effect of hypertension on fibronectin expression in the rat aorta. , 1990, The Journal of biological chemistry.
[33] HiroakiMatsubara. Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases , 1998 .
[34] S M Schwartz,et al. Developmental mechanisms underlying pathology of arteries. , 1990, Physiological reviews.
[35] K. Weber,et al. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. , 1994, Journal of molecular and cellular cardiology.
[36] Erkki Ruoslahti,et al. Proteoglycans as modulators of growth factor activities , 1991, Cell.
[37] A. Sabri,et al. Fibronectin and basement membrane in cardiovascular organogenesis and disease pathogenesis. , 1996, Cardiovascular research.
[38] J. Schaper,et al. The extracellular matrix in human cardiac tissue. Part II: Vimentin, laminin, and fibronectin. , 1992, Cardioscience.
[39] Y. Toya,et al. Mechanism of Angiotensin II-mediated Regulation of Fibronectin Gene in Rat Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.
[40] J. Schwarzbauer. Fibronectin: from gene to protein. , 1991, Current opinion in cell biology.
[41] D C Rees,et al. Heparin Structure and Interactions with Basic Fibroblast Growth Factor , 1996, Science.
[42] J. Schaper,et al. The extracellular matrix in the failing human heart. , 1992, Basic research in cardiology.
[43] Kenneth M. Yamada,et al. Integrin transmembrane signaling and cytoskeletal control. , 1995, Current opinion in cell biology.
[44] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[45] A. Chobanian,et al. Fibronectin biosynthesis in the rat aorta in vitro. Changes due to experimental hypertension. , 1991, The Journal of clinical investigation.
[46] K. Weber,et al. Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin. , 1996, Cardiovascular research.
[47] J. Keiser,et al. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. , 1998, Circulation research.
[48] C. Long,et al. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. , 1998, Cardiovascular research.
[49] Hisahiro Yu,et al. Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression. , 1997, Hypertension.
[50] A. Chobanian,et al. Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts. , 1996, Circulation research.
[51] 今井 泰平. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells , 1993 .
[52] S. Schwartz,et al. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). , 1991, Biochemical and biophysical research communications.
[53] P. R. Myers,et al. Vascular endothelial cell regulation of extracellular matrix collagen: role of nitric oxide. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[54] R. Weiss,et al. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF , 1993, The Journal of cell biology.
[55] Lorell Bh. Transition from hypertrophy to failure. , 1997 .
[56] J. Thyberg,et al. Role of tyrosine kinases in extracellular matrix-mediated modulation of arterial smooth muscle cell phenotype. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[57] J. S. Janicki,et al. Remodeling of the rat right and left ventricles in experimental hypertension. , 1990, Circulation research.
[58] Y. Yazaki,et al. Is there major involvement of the renin-angiotensin system in cardiac hypertrophy? , 1997, Circulation research.
[59] C. Mickanin,et al. Cell adhesion receptors and early mammalian heart development: an overview. , 1993, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[60] K. Tryggvason,et al. The laminin family. , 1993, Current opinion in cell biology.
[61] V. Koteliansky,et al. Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells , 1996, The Journal of cell biology.
[62] C. Delcayre,et al. Biological determinants of aldosterone-induced cardiac fibrosis in rats. , 1995, Hypertension.
[63] K. Weber,et al. Cardiac interstitium in health and disease: the fibrillar collagen network. , 1989, Journal of the American College of Cardiology.
[64] M. Glukhova,et al. Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats. , 1993, Hypertension.
[65] R. Hynes,et al. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. , 1993, Development.
[66] M. Sporn,et al. Transforming growth factor-beta: recent progress and new challenges , 1992, The Journal of cell biology.
[67] G. Hamon,et al. HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro. , 1997, The Journal of pharmacology and experimental therapeutics.
[68] D E Ingber,et al. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. , 1995, Molecular biology of the cell.
[69] T K Borg,et al. Expression of collagen binding integrins during cardiac development and hypertrophy. , 1991, Circulation research.
[70] C. Long,et al. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-b and endothelin-1 from fibroblasts 1 , 1998 .
[71] T. Borg,et al. Potential Role of the Extracellular Matrix in Postseptation Development of the Heart a , 1990, Annals of the New York Academy of Sciences.
[72] S. Chien,et al. Role of integrins in cellular responses to mechanical stress and adhesion. , 1997, Current opinion in cell biology.
[73] Y. Kihara,et al. Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. , 1997, Circulation research.
[74] W. Hsueh,et al. Integrins, adhesion, and cardiac remodeling. , 1998, Hypertension.
[75] S. Shapiro,et al. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. , 1998, Current opinion in cell biology.
[76] K. Tryggvason,et al. Primary structure and expression of a novel human laminin alpha 4 chain. , 1995, FEBS letters.
[77] G. Laurent,et al. Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. , 1995, European journal of cell biology.
[78] C. Lechene,et al. Adhesion is required for protein kinase C-dependent activation of the Na+/H+ antiporter by platelet-derived growth factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[79] B. Lorell. Transition from hypertrophy to failure. , 1997, Circulation.
[80] K. Tryggvason,et al. Primary structure and expression of a novel human laminin α4 chain , 1995 .
[81] V. Koteliansky,et al. Specific alterations in the distribution of extracellular matrix components within rat myocardium during the development of pressure overload. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[82] Y. Yazaki,et al. Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. Possible role of protein kinase C activation. , 1991, The Journal of biological chemistry.
[83] H. Nagase. Matrix metalloproteinases. A mini-review. , 1994, Contributions to nephrology.
[84] M. Mulvany. Resistance vessel growth and remodelling: cause or consequence in cardiovascular disease. , 1995, Journal of human hypertension.
[85] A. Mebazaa,et al. Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. , 1997, Circulation research.
[86] M. Bissell,et al. Multi‐faceted regulation of cell differentiation by extracellular matrix , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[87] P. Douglas,et al. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. , 1996, Circulation.
[88] J. Thiery,et al. Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload. , 1991, The Journal of clinical investigation.
[89] P. Poitevin,et al. Differential roles of AT1 and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[90] A. Tedgui,et al. Signal transduction of mechanical stresses in the vascular wall. , 1998, Hypertension.
[91] H. Ives,et al. Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells. , 1993, The Journal of clinical investigation.
[92] E. Fleck,et al. Myocardial osteopontin expression is associated with left ventricular hypertrophy. , 1997, Circulation.
[93] F. Villarreal,et al. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. , 1992, The American journal of physiology.
[94] Jussi Taipale,et al. Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[95] A. Sabri,et al. Expression of fibronectin during rat fetal and postnatal development: an in situ hybridisation and immunohistochemical study. , 1994, Cardiovascular research.
[96] J. Schaper,et al. Extracellular matrix deposition in hypertensive hearts antifibrotic effects of ramipril. , 1995, European heart journal.
[97] T. Lüscher,et al. Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist. , 1997, Circulation.
[98] S. Haskill,et al. Signal transduction from the extracellular matrix , 1993, The Journal of cell biology.